HCPCS Level IIdrugActive
J9353
Inj. margetuximab-cmkb, 5 mg
BETOS: O1D
Effective: 2021-07-01
Description
Injection, margetuximab-cmkb, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Margenza
Manufacturer
MacroGenics, Inc
HCPCS Dosage
5 MG
Billing Units
50.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.